Brief: New Indication Approved For Guerbet’s Lipiodol Ultra Fluid
Sept 11 (Reuters) - GUERBET SA GRBT.PA :
* NEW INDICATION APPROVED FOR GUERBET’S LIPIODOL ULTRA FLUID IN BELGIUM, IRELAND, PORTUGAL,
HONG-KONG AND THE PHILIPPINES
* LIPIODOL ULTRA FLUID NOW APPROVED FOR CONVENTIONAL TRANS-ARTERIAL CHEMOEMBOLIZATION OF
INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA
Source text: https://bit.ly/2CLjHbw
Further company coverage: GRBT.PA
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Guerbet SA
See all newsBrief: Guerbet Q1 Revenue At EUR 177.4 Mln
Guerbet Q1 revenue up 2.6% at CER on increased volumes in EMEA and Asia
Medical imaging firm Guerbet's 2025 revenue falls on lower sales activity in France
Brief: Guerbet Says FDA Approves Labeling Update For Guerbet's Elucirem Injection
France's Guerbet misses 2025 revenue estimates